122 related articles for article (PubMed ID: 38141552)
1. Survival outcomes and prognostic factors of infratentorial glioblastoma in the elderly.
Chandra A; Lopez-Rivera V; Ryba B; Chandran AS; Brandel MG; Dono A; Sheinberg DL; Esquenazi YL; Aghi MK
Clin Neurol Neurosurg; 2024 Jan; 236():108084. PubMed ID: 38141552
[TBL] [Abstract][Full Text] [Related]
2. Comparative Analysis of Survival Outcomes and Prognostic Factors of Supratentorial versus Cerebellar Glioblastoma in the Elderly: Does Location Really Matter?
Chandra A; Lopez-Rivera V; Dono A; Brandel MG; Lewis C; O'Connor KP; Sheth SA; Ballester LY; Aghi MK; Esquenazi Y
World Neurosurg; 2021 Feb; 146():e755-e767. PubMed ID: 33171326
[TBL] [Abstract][Full Text] [Related]
3. Comparison of survival between cerebellar and supratentorial glioblastoma patients: surveillance, epidemiology, and end results (SEER) analysis.
Jeswani S; Nuño M; Folkerts V; Mukherjee D; Black KL; Patil CG
Neurosurgery; 2013 Aug; 73(2):240-6; discussion 246; quiz 246. PubMed ID: 23615082
[TBL] [Abstract][Full Text] [Related]
4. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
5. Cerebellar glioblastoma multiforme: a retrospective study of 28 patients at a single institution.
Yang S; Liu J; Wang T; Li X; You C
Int J Neurosci; 2013 Oct; 123(10):691-7. PubMed ID: 23550813
[TBL] [Abstract][Full Text] [Related]
6. Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis.
Wen J; Chen W; Zhu Y; Zhang P
BMC Cancer; 2021 Jan; 21(1):81. PubMed ID: 33468109
[TBL] [Abstract][Full Text] [Related]
7. Outcomes and Patterns of Care in Elderly Patients with Glioblastoma Multiforme.
Nunna RS; Khalid SI; Patel S; Sethi A; Behbahani M; Mehta AI; Adogwa O; Byrne RW
World Neurosurg; 2021 May; 149():e1026-e1037. PubMed ID: 33482415
[TBL] [Abstract][Full Text] [Related]
8. Safety and outcomes of resection of butterfly glioblastoma.
Dayani F; Young JS; Bonte A; Chang EF; Theodosopoulos P; McDermott MW; Berger MS; Aghi MK
Neurosurg Focus; 2018 Jun; 44(6):E4. PubMed ID: 29852771
[TBL] [Abstract][Full Text] [Related]
9. The butterfly effect on glioblastoma: is volumetric extent of resection more effective than biopsy for these tumors?
Chaichana KL; Jusue-Torres I; Lemos AM; Gokaslan A; Cabrera-Aldana EE; Ashary A; Olivi A; Quinones-Hinojosa A
J Neurooncol; 2014 Dec; 120(3):625-34. PubMed ID: 25193022
[TBL] [Abstract][Full Text] [Related]
10. Combined-Modality Therapy With Radiation and Chemotherapy for Elderly Patients With Glioblastoma in the Temozolomide Era: A National Cancer Database Analysis.
Rusthoven CG; Koshy M; Sher DJ; Ney DE; Gaspar LE; Jones BL; Karam SD; Amini A; Ormond DR; Youssef AS; Kavanagh BD
JAMA Neurol; 2016 Jul; 73(7):821-8. PubMed ID: 27214765
[TBL] [Abstract][Full Text] [Related]
11. Extent of resection and radiotherapy in GBM: A 1973 to 2007 surveillance, epidemiology and end results analysis of 21,783 patients.
Zinn PO; Colen RR; Kasper EM; Burkhardt JK
Int J Oncol; 2013 Mar; 42(3):929-34. PubMed ID: 23338774
[TBL] [Abstract][Full Text] [Related]
12. Extent of resection and survival outcomes of geriatric patients with glioblastoma: Is there benefit from aggressive surgery?
Lopez-Rivera V; Dono A; Lewis CT; Chandra A; Abdelkhaleq R; Sheth SA; Ballester LY; Esquenazi Y
Clin Neurol Neurosurg; 2021 Mar; 202():106474. PubMed ID: 33454497
[TBL] [Abstract][Full Text] [Related]
13. Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Data Base.
Amsbaugh MJ; Yusuf MB; Gaskins J; Burton EC; Woo SY
Cancer; 2017 Sep; 123(17):3277-3284. PubMed ID: 28452053
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients.
Shields LB; Shelton BJ; Shearer AJ; Chen L; Sun DA; Parsons S; Bourne TD; LaRocca R; Spalding AC
Radiat Oncol; 2015 Oct; 10():222. PubMed ID: 26520780
[TBL] [Abstract][Full Text] [Related]
15. Primary glioblastoma multiforme in younger patients: a single-institution experience.
Ulutin C; Fayda M; Aksu G; Cetinayak O; Kuzhan O; Ors F; Beyzadeoglu M
Tumori; 2006; 92(5):407-11. PubMed ID: 17168433
[TBL] [Abstract][Full Text] [Related]
16. OLIG2 expression level could be used as an independent prognostic factor for patients with cerebellar Glioblastoma (cGBM).
Zhou J; Shi LF; Wang Z; Li M; Zhang JS; Mao Y; Hua W
Clinics (Sao Paulo); 2023; 78():100120. PubMed ID: 37001387
[TBL] [Abstract][Full Text] [Related]
17. Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients.
Tanaka S; Meyer FB; Buckner JC; Uhm JH; Yan ES; Parney IF
J Neurosurg; 2013 Apr; 118(4):786-98. PubMed ID: 23176331
[TBL] [Abstract][Full Text] [Related]
18. Impact of timing to initiate adjuvant therapy on survival of elderly glioblastoma patients using the SEER-Medicare and national cancer databases.
Zhu P; Du XL; Hwang LY; Lairson D; Li R; Esquenazi Y; Zhu JJ
Sci Rep; 2023 Feb; 13(1):3266. PubMed ID: 36841851
[TBL] [Abstract][Full Text] [Related]
19. Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy.
Kreth FW; Thon N; Simon M; Westphal M; Schackert G; Nikkhah G; Hentschel B; Reifenberger G; Pietsch T; Weller M; Tonn JC;
Ann Oncol; 2013 Dec; 24(12):3117-23. PubMed ID: 24130262
[TBL] [Abstract][Full Text] [Related]
20. Effect of Gross Total Resection in World Health Organization Grade II Astrocytomas: SEER-Based Survival Analysis.
Schupper AJ; Hirshman BR; Carroll KT; Ali MA; Carter BS; Chen CC
World Neurosurg; 2017 Jul; 103():741-747. PubMed ID: 28419878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
